These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Viewpoint: mismatch between the European and American guidelines on oral antiplatelet P2Y12 inhibitors after acute coronary syndromes. Serebruany VL; DiNicolantonio JJ Thromb Haemost; 2013 Jul; 110(1):5-10. PubMed ID: 23743577 [TBL] [Abstract][Full Text] [Related]
8. Ticagrelor or prasugrel versus clopidogrel in elderly patients with an acute coronary syndrome: Optimization of antiplatelet treatment in patients 70 years and older--rationale and design of the POPular AGE study. Qaderdan K; Ishak M; Heestermans AA; de Vrey E; Jukema JW; Voskuil M; de Boer MJ; van't Hof AW; Groenemeijer BE; Vos GJ; Janssen PW; Bergmeijer TO; Kelder JC; Deneer VH; ten Berg JM Am Heart J; 2015 Nov; 170(5):981-985.e1. PubMed ID: 26542508 [TBL] [Abstract][Full Text] [Related]
9. Comparison of prasugrel and clopidogrel-treated patients with acute coronary syndrome undergoing percutaneous coronary intervention: A propensity score-matched analysis of the Acute Myocardial Infarction in Switzerland (AMIS)-Plus Registry. Kurz DJ; Radovanovic D; Seifert B; Bernheim AM; Roffi M; Pedrazzini G; Windecker S; Erne P; Eberli FR Eur Heart J Acute Cardiovasc Care; 2016 Feb; 5(1):13-22. PubMed ID: 25614494 [TBL] [Abstract][Full Text] [Related]
10. NSTE-ACS ESC Guidelines Recommend Prasugrel as the Preferred P2Y12 Inhibitor: A Contrarian View. Angoulvant D; Sabouret P; Savage MP Am J Cardiovasc Drugs; 2021 Sep; 21(5):483-486. PubMed ID: 33674980 [TBL] [Abstract][Full Text] [Related]
12. Characteristics of new P2Y12 inhibitors: selection of P2Y12 inhibitors in clinical practice. Golino P J Cardiovasc Med (Hagerstown); 2013 Dec; 14 Suppl 1():S22-30. PubMed ID: 24378838 [TBL] [Abstract][Full Text] [Related]
13. P2Y12 inhibition in acute coronary syndromes treated with percutaneous intervention - Understanding the debate on Prasugrel or Ticagrelor. Schäfer A; Bauersachs J Pharmacol Ther; 2022 May; 233():108029. PubMed ID: 34740747 [TBL] [Abstract][Full Text] [Related]
14. New antiplatelet agents in the treatment of acute coronary syndromes. Sabouret P; Taiel-Sartral M Arch Cardiovasc Dis; 2014 Mar; 107(3):178-87. PubMed ID: 24630752 [TBL] [Abstract][Full Text] [Related]
15. Optimal cutoff value of P2Y12 reaction units to prevent major adverse cardiovascular events in the acute periprocedural period: post-hoc analysis of the randomized PRASFIT-ACS study. Nakamura M; Isshiki T; Kimura T; Ogawa H; Yokoi H; Nanto S; Takayama M; Kitagawa K; Ikeda Y; Saito S Int J Cardiol; 2015 Mar; 182():541-8. PubMed ID: 25679803 [TBL] [Abstract][Full Text] [Related]
16. Prehospital administration of P2Y12 inhibitors and early coronary reperfusion in primary PCI: an observational comparative study. De Backer O; Ratcovich H; Biasco L; Pedersen F; Helqvist S; Saunamäki K; Tilsted HH; Clemmensen P; Olivecrona G; Kelbaek H; Jørgensen E; Engstrøm T; Holmvang L Thromb Haemost; 2015 Aug; 114(3):623-31. PubMed ID: 25994355 [TBL] [Abstract][Full Text] [Related]
17. Contemporary antithrombotic strategies in patients with acute coronary syndrome admitted to cardiac care units in Italy: The EYESHOT Study. De Luca L; Leonardi S; Cavallini C; Lucci D; Musumeci G; Caporale R; Abrignani MG; Lupi A; Rakar S; Gulizia MM; Bovenzi FM; De Servi S; Eur Heart J Acute Cardiovasc Care; 2015 Oct; 4(5):441-52. PubMed ID: 25414322 [TBL] [Abstract][Full Text] [Related]
18. Novel oral P2Y12 inhibitor prasugrel vs. clopidogrel in patients with acute coronary syndrome: evidence based on 6 studies. Jia M; Li Z; Chu H; Li L; Chen K Med Sci Monit; 2015 Apr; 21():1131-7. PubMed ID: 25893318 [TBL] [Abstract][Full Text] [Related]
19. Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial. Nicolau JC; Bhatt DL; Roe MT; Lokhnygina Y; Neely B; Corbalán R; Leiva-Pons JL; Martinez F; Goodman SG; Winters KJ; Verheugt FW; Armstrong PW; White HD; Fox KA; Prabhakaran D; Ohman EM; Am Heart J; 2015 Oct; 170(4):683-694.e3. PubMed ID: 26386792 [TBL] [Abstract][Full Text] [Related]
20. Implementation of contemporary oral antiplatelet treatment guidelines in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a report from the GReek AntiPlatelet rEgistry (GRAPE). Alexopoulos D; Goudevenos JA; Xanthopoulou I; Deftereos S; Sitafidis G; Kanakakis I; Hamilos M; Parissis H; Ntalas IV; Angelidis C; Petousis S; Vavuranakis M; Hahalis G; Stefanadis C; Int J Cardiol; 2013 Oct; 168(6):5329-35. PubMed ID: 23978364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]